Lataa...
Dual-Action Inhibitors of HIF Prolyl Hydroxylases That Induce Binding of a Second Iron Ion
Inhibition of the hypoxia-inducible factor (HIF) prolyl-hydroxylases (PHD or EGLN enzymes) is of interest for the treatment of anemia and ischemia-related diseases. Most PHD inhibitors work by binding to the single ferrous ion and competing with 2-oxoglutarate (2OG) co-substrate for binding at the P...
Tallennettuna:
Julkaisussa: | Org Biomol Chem |
---|---|
Päätekijät: | , , , , , , , , , , , , , , |
Aineistotyyppi: | Artigo |
Kieli: | Inglês |
Julkaistu: |
2012
|
Aiheet: | |
Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4677462/ https://ncbi.nlm.nih.gov/pubmed/23151668 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1039/c2ob26648b |
Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|